AzTrials
AzTrials

PeritonitisDIVERTINCT00692393

Primary vs. Secondary Anastomosis for Hinchey Stage III-IV Diverticulitis a Prospective Randomized Trial

A study testing Hartmann intervention and Protected anastomosis resection in people with Peritonitis, run by University Hospital, Rouen at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study compares primary resection with anastomosis and Hartmann's procedure in an adult population with acute perforated colonic diverticulitis (Hinchey Stage III and IV) METHODS: The primary end point was postoperative mortality. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Peritonitis
What is being tested?
Hartmann intervention and Protected anastomosis resection
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
102 participants
Where
1 siteFrance
Study dates
Jun 2008to Nov 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient with peritonitis du to sigmoid diverticulum complication
  • Surgeon - anesthetist confirming the 2 surgeries can be performed

Who cannot join

  • Physical state which can not permit patient to participate
  • contraindication to surgery
  • non-diverticulum peritonitis

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU - Rouen

    Rouen, 76031

Other trials in France

About this study

Official title: Primary vs. Secondary Anastomosis After Sigmoid Colon Resection for Perforated Diverticulitis (Hinchey Stage III and IV): a Prospective Multicentric Randomized Trial

This study compares primary resection with anastomosis and Hartmann's procedure in an adult population with acute perforated colonic diverticulitis (Hinchey Stage III and IV) METHODS: The primary end point was postoperative mortality. Secondary end points included surgical and medical morbidity, operative time, and length of postoperative hospitalization.

Read the detailed description

inclusion criteria: hinchey III and IV diverticulitis

Conditions
Peritonitis
Being tested
Hartmann intervention, Protected anastomosis resection
Medical subject headings
Peritonitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hartmann interventionProcedure or surgery

    sigmoid resection, peritoneal and rectal lavage, terminal stoma

  • Protected anastomosis resectionProcedure or surgery

    sigmoid resection , peritoneal and rectal lavage, anastomosis, diverting stoma

Study groups in NCT00692393
Study groupRoleWhat they receive
1Active comparatorSurgery : Hartmann intervention
Receives: Procedure: Hartmann intervention
2ExperimentalSurgery : primary resection with anastomosis with protective stoma
Receives: Procedure: Protected anastomosis resection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Death rate comparison between two chirurgical strategies

    Measured: 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jun 2008 (estimated)
  2. Study startJun 2008
  3. Primary completionDec 2012
  4. Study completionNov 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
102 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00692393
Sponsor's protocol ID
2006/103/HP
Acronym
DIVERTI
Status last verified
Apr 2026
First submitted
3 Jun 2008
Last updated
16 Apr 2026
Results posted
No
Data monitoring committee
No

Publications

  • Tuech JJ, Bridoux V. Randomized Clinical Trial (DIVERTI) and Ethical Considerations: In reply to Fujita. J Am Coll Surg. 2018 Mar;226(3):336-337. doi: 10.1016/j.jamcollsurg.2017.12.006. No abstract available.

    PubMed 29478474
  • Bridoux V, Regimbeau JM, Ouaissi M, Mathonnet M, Mauvais F, Houivet E, Schwarz L, Mege D, Sielezneff I, Sabbagh C, Tuech JJ. Hartmann's Procedure or Primary Anastomosis for Generalized Peritonitis due to Perforated Diverticulitis: A Prospective Multicenter Randomized Trial (DIVERTI). J Am Coll Surg. 2017 Dec;225(6):798-805. doi: 10.1016/j.jamcollsurg.2017.09.004. Epub 2017 Sep 22.

    PubMed 28943323

Questions about this trial

What is this clinical trial studying?

A study testing Hartmann intervention and Protected anastomosis resection in people with Peritonitis, run by University Hospital, Rouen at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Death rate comparison between two chirurgical strategies (time frame: 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00692393, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in